Revive Therapeutics Ltd (RVVTF)

[Nosnibor]

Anticipating a continued upward surge particularly between now and mid-March given the most recent news. I am currently looking at selling some of my other investments and significantly increasing my (already significant) investment in Revive's (patented) Bucillamine. In my opinion it is a rare opportunity and indeed relief to be in a credible OTC stock these days.